Brief: IRLAB Therapeutics April-June Operating Loss Widens To SEK 44.9 Mln

IRLAB Therapeutics AB

30/08/2023 06:10

Aug 30 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * APRIL-JUNE NET SALES RECORDED: SEK 6.9M (SEK 23.4M)
    * APRIL-JUNE OPERATING RESULT: SEK -44.9M (SEK -27.0M)

Source text for Eikon:  ID:nMFN3lYJlr 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))